The 64-year-old female patient was admitted with atypical chest pain and a history of CAD (NSTEMIs x 2 in 1997/2001, cath 2000 RCA, LCx in 2000, which were complicated by in-stent thrombosis ?3 years ago), HTN, DM (hba1c 6.2), PVD. In the ED, BP 159/69, P 60. No EKG changes new. First set of enzymes negative. D dimer negative. She underwent chemical-MIBI on 6/25 which was negative for any acute or reversible changes (final P). Her pain was only controlled with oxycodone and she was pain-free at discharge. Pt was discharged to home with follow-up already scheduled with Dr. Hassenger, her cardiologist at the end of the month. She was continued on ECASA (Aspirin Enteric Coated) 81 MG PO 3x/Week M-W-F, LISINOPRIL 1.25 MG PO QD (with POTENTIALLY SERIOUS INTERACTION: POTASSIUM CHLORIDE & LISINOPRIL), PLAVIX (Clopidogrel) 75 MG PO QD, ATENOLOL 50 MG PO QD, LIPITOR (Atorvastatin) 40 MG PO QD, and GLYBURIDE 1.25 MG PO QD. Of note, pt had an elevated WBC (15.2) which seems to be chronic in nature. No fevers, localizing signs/symptoms of infection. Pt has follow-up with cardiology and vascular surgery scheduled. No new medications this admission.
Has the patient ever had plavix (clopidogrel)
PLAVIX (Clopidogrel) 75 MG PO QD